{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"12"}]}],"title":"Positive CMV Viral Load Assay"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}],"title":"Symptomatic CMV disease"}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"17"}],"units":"Participants"}],"description":"polymerase chain reaction testing for presence of CMV weekly until at least day +100 then every 2 weeks until T-cell reconstitution as defined by cluster of differentiation 4 (CD4) \\> 200 cells/mm3. Median time to T-cell reconstitution was 6 months.","groups":[{"description":"\"seronegativity\" means no detected presence of anti-CMV IgG, indicating no past infection by the virus","id":"OG000","title":"CMV Seronegative Participants"},{"description":"\"seropositivity\" means the presence of anti-CMV IgG, indicating past infection by the virus","id":"OG001","title":"CMV Seropositive Participants"}],"paramType":"NUMBER","populationDescription":"4 participants were incapable of producing Ab or CMV testing result was indeterminate","reportingStatus":"POSTED","timeFrame":"Up to one year post-transplant","title":"Cytomegalovirus (CMV) Viral Infection and Disease Symptoms","type":"SECONDARY","unitOfMeasure":"participants"}